Many countries in EECA substantially rely on international funding to tackle HIV and TB, and

Similar documents
Reflecting on ten years of progress in the fight against AIDS, TB and malaria

Alcohol-related harm in Europe and the WHO policy response

European status report on alcohol and health Leadership, awareness and commitment

The cancer burden in the European Union and the European Region: the current situation and a way forward

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

CONCEPT NOTE. Addressing HIV and TB Challenges: from Donor Support to Sustainable Health Systems

80% Challenges & MORE new HIV cases compared to TRANSITIONING FROM DONOR SUPPORT HIV & TB Programmes 80% HIV IN EUROPE

80% Challenges & MORE new HIV cases compared to TRANSITIONING FROM DONOR SUPPORT HIV & TB Programmes 80% HIV IN EUROPE

Inequalities in health: challenges and opportunities in Europe Dr Zsuzsanna Jakab WHO Regional Director for Europe

Progress on the targets of Millennium Development Goal 6 in central and eastern Europe and central Asia

Key issues for HIV testing and

Smokefree Policies in Europe: Are we there yet?

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Better Health for All in Latvia

Where we stand in EFORT

Combating HIV/AIDS and TB in Eastern Europe and Central Asia: The World Bank Response

European Status report on Alcohol and Health

HIV/AIDS Joint Action HA-REACT

WCPT COUNTRY PROFILE December 2017 SERBIA

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 HUNGARY

TB/HIV in the WHO European Region Overview, Priorities & Response

Q1 What age are you?

Dr. Mark R. Dybul Executive Director of the Global Fund to Fight AIDS Tuberculosis and Malaria

Implementing the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2010 Progress Report SPECIAL REPORT.

Overview of drug-induced deaths in Europe - What does the data tell us?

Highlighting in the WHO European Region: Summary. No. 21(February 2012)

Access to treatment and disease burden

Situation update in the European Region: overview of influenza surveillance data week 40/2009 to week 07/2010.

Underage drinking in Europe

Development of Palliative Care services in different countries

Animal health situation of OIE Member Countries in Europe 1 st semester 2012 (and previous)

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

May 26-28, 2010, Almaty, Kazakhstan November 2011

Engagement in language assessment / Regions of Europe

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

World Health Organization Regional Office for Europe Surveillance of measles and rubella Data as of 15 March 2006

The challenge of obesity in the WHO European Region

Cross Border Genetic Testing for Rare Diseases

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.

EUDY JUNIOR CAMP 2018 FIRST ANNOUNCEMENT

Highlighting in the WHO European Region: measles outbreaks rubella surveillance acute flaccid paralysis surveillance

Turning the Tide Against HIV and Tuberculosis. Global Fund Investment Guidance for Eastern Europe and Central Asia

Highlighting in the WHO European Region:

Inequality in injury risks

OSI s Activities in HIV/AIDS, Tuberculosis, and STIs. Initiatives in Central and Eastern Europe and the former Soviet Union

Regional program of the East Europe and Central Asia Union of PLWH within the framework of the Global Fund New Funding Model

Background Past Present Future

EURO POLIO PAGE Data as of 04 October 2005 (Week 38)

Introducing. the WHO Regional Office for Europe

MINUTES AIDS ACTION EUROPE STEERING COMMITTEE MEETING OPENING AND FOLLOW-UP FROM PREVIOUS SC MEETING

Measuring TB burden and access to TB services for people who inject drugs in the WHO European Region, 2010 and 2011

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

Monthly measles and rubella monitoring report

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

Overall survival: 1 st line therapy

Information about activities in the region of possible relevance for the regional strategic plan. GF-TADs for Europe

Summary. Primary care data. Week 49/2014. Season

On 24 May 2005 the Council (GAERC), in its formation of Development Ministers, adopted the conclusions in Annex I.

The Identification of Food Safety Priorities using the Delphi Technique

COMMISSION OF THE EUROPEAN COMMUNITIES

Hep-CORE, Marinela Debu, ELPA vice-president & APAH-RO president

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

Access to HCV treatment in Europe

Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe

The Global Summit of Women 2009 Santiago, Chile May 14-16

The Global Fund s view on transition Dumitru Laticevschi The Global Fund

CALL FOR A EUROPEAN ACTION PLAN FOR MEDICAL IMAGING TO IMPROVE QUALITY OF CARE AND PATIENT SAFETY

Priorities for achieving Millennium Development Goals (MDGs) 4 and 5 in the European Region

Who is a migrant? 12/10/2018. HIV and migrants. Heterogeneous groups of persons with different migration drivers

Real Life, Real PD Survey

BACKGROUND PAPER OF THE EUROPEAN UNION 1 ON THE OCCASION OF THE HIGH-LEVEL MEETING TO REVIEW THE PROCESS ACHIEVED IN

European Collaboration on Dementia. Luxembourg, 13 December 2006

Positioning health equity and the social determinants of health on the regional development agenda Investment for health and development in Slovenia

Analysis of 3-dose oral/inactivated poliovirus vaccine (OPV3/IPV3) immunization coverage

Department of Biological Standardisation OMCL Network & Healthcare (DBO)

Alcohol Prevention Day

Comparative analysis of nutrition policies in the WHO European Region

Long Term Forensic Psychiatric Care in the Netherlands. Peter Braun Pompestichting Nijmegen/Zeeland/Vught. 8th of November 2018

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Financing the Response to HIV/AIDS in Low and Middle Income Countries: Funding for HIV/AIDS from the G7 and the European Commission

SUMMARY OF INTERIM REPORT

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

LEBANON. WCPT COUNTRY PROFILE December 2018

GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy

Primary and secondary prevention of sudden cardiac death in emerging economies

Injuries in Europe: a call for public health action An update from 2008 WHO Global Burden of Disease

Key Highlights continued

Transcription:

To: Mr Taavi Rõivas, Prime Minister of Estonia CC: Mr Jevgeni Ossinovski, Minister of Health and Labor Ms Marina Kaljurand, Minister of Foreign Affairs Mr Margus Tsahkna, Minister for Social Protection Ms Kaja Tael, Ambassador, Permanent Representative of Estonian to the EU Brussels, 12 September, 2016 Subject: 2017 Estonian Presidency of the European Union Dear Mr Rõivas, In view of the upcoming Estonian Presidency of the Council of the European Union in 2017, the undersigned 66 organizations from 34 European countries would like to urge Estonia to prioritize the issue of funding crisis for tuberculosis (TB), HIV, hepatitis B and C (HCV) programmes in the European region in your Presidency s health agenda. The region of Eastern Europe and Central Asia (EECA) is home to the fastest growing HIV and HCV epidemics and the highest rates of multi-drug resistant TB (MDR-TB) in the world. According to WHO, 2013 there were 80% more new HIV cases in Europe compared to 2004 1. UNAIDS considers the EECA as the only region in the world where HIV prevalence continues to grow 2. At the same time, in many countries of the European region, rates of MDR-TB 3 are alarming. EECA has the world s highest rates of new TB patients with MDR-TB 4, which has become an epidemic on its own, and TB is among one of the leading causes of death of HIV positive people in the region. Moreover, in many countries hepatitis C prevalence nears 80% in people who use drugs 5 and the number of related deaths rises yearly. In addition to the catastrophic human cost, the economic burden caused by TB in the region is enormous. It is estimated that by 2050, drug resistant TB will be responsible for an additional 2.1 million deaths at an economic cost of $1.1 trillion in Europe 6. This is an appalling situation for the European region, which, compared to many other regions in the world, has much higher living standards and more stable political, economic and social situation, thus should be better positioned to fight these deadly diseases. It is in the EU's best interest to prevent HIV and TB epidemics from crippling Europe's social and economic development. Many countries in EECA substantially rely on international funding to tackle HIV and TB, and 1 WHO Infographic, HIV in Europe, November 2014, http://www.euro.who.int/ data/assets/pdf_file/0008/264788/infographic -HIV-in- Europe-80-percent-more-600-Eng.pdf 2 UNAIDS GAP Report 2014 http://www.unaids.org/en/resources/documents/2014/20140716_unaids_gap_report 3 MDR-TB - a form of the disease that does not respond to the standard treatment of TB drugs and is much more difficult and costly to treat 4 Global Tuberculosis Report 2013, World Health Organisation, http://www.who.int/tb/publications/global_report/en/ 5 Harm Reduction International. The Global State of Harm Reduction 2014 https://www.hri.global/files/2015/02/16/gshr2014.pdf 6 Review on Anti-Microbial Resistance, May 2016, Jim O Neill

national funding for HCV is absent. External donor funding is still very often the main source to finance programmes targeting vulnerable groups and key affected populations. With economic growth in the region, EECA countries are gradually becoming ineligible for development assistance. The phasing out of international donors, such as the Global Fund to Fight AIDS, TB and Malaria and USAID, is raising concerns that funding gaps may not be met by increases in domestic funding, putting at risk the progress made so far in the TB and HIV response. In view of the recent progress made in TB and HIV in Estonia and with very successful transition from donor to domestic funding in the country, we are calling on the Estonian government to seize the unique opportunity of the upcoming Presidency of the Council of the European Union to play a leadership role by including TB and HIV in the European region as one of its health priorities. In particular, we ask the Estonian government to convene within its presidency a High Level Meeting to discuss and agree on concrete roadmaps for filling the financial gaps and increase the political commitment to eliminate TB, viral hepatitis and HIV in the region. The Eastern Partnership Summit could be a good platform for such a High Level Event, bringing together all stakeholders from EECA. We, as civil society, stay at the Estonian government s disposal for any kind of support for discussions on funding and transition issues and believe that together we will be able to generate the much needed regional political leadership to start turning the tide of the TB, viral hepatitis and HIV epidemics in Europe. Yours sincerely, Act For Involvement (Moldova) Georgian Harm Reduction Network (Georgia) ADHARA (Spain) Global Health Advocates AGIHAS - support group for people living with HIV and AIDS (Latvia) Grupo de Ativistas em Tratamentos (Portugal) AIDES (France) Healthy Options Project Skopje (Macedonia) AIDS Action Europe Hepatitis, AIDS, Research Trust

Aids Hilfe (Austria) HIV Ireland AIDS Solidarity Movement (Cyprus) HPLGBT (Ukraine) AIDS-Fondet (Denmark) International HIV Partnerships AIDS-Hilfe Steiermark (Austria) I Can Live Coalition of NGOs and Experts (Lithuania) AJPAS (Portugal) Life Quality Improvement Organisation Flight (Croatia) Ameliya OO (Kazakhstan) Medical Foundation for HIV & Sexual Health (UK) Apoyo Positivo (Spain) menzdrav Foundation (Russia and Ukraine) Association HIV.LV (Latvia) National AIDS Trust (UK) CASO - Associated Users Survive United (Portugal) New Life AIDS (Russia)

CAZAS NGO (Montenegro) "Positive People Armenian Network" Soc. NGO (Armenia) Center For The Empowerment Youth Of People Who Are Living With HIV and AIDS (Serbia) Positive Voice (Greece) Civic Association Odyseus (Slovakia) Public Foundation "Kyrgyz Coalition for TB "Coalition against Tuberculosis" (Kyrgyzstan) Civil Society Organisations Forum on HIV and AIDS (FOCDHA) (Serbia) Q-klub (Serbia) Convictus (Ukraine) RESULTS UK Coomunity of PLHIV (Uzbekistan) Romanian Angel Appeal Foundation (Romania) Coordinadora estatal de VIH y sida (Spain) Romanian Harm Reduction Network (Romania) CORRELATION Network (Netherlands) Czech AIDS Help Society (Czech Republic) SALUS Charitable Foundation (Ukraine) Sens Pozitiv Association (Romania) Demetra, Association of HIV affected women and their families (Lithuania) SENSOA (Belgium)

"Dose of love" Association (Bulgaria) SKUC Association (Slovenia) East Europe and Central Asia Union of People Living with HIV (ECUO) Stop AIDS Alliance (Belgium) Estonian Network of PLWH (Estonia) STOP TB Partnership Coalition (Tajikistan) Eurasian Coalition on Male Health (ECOM) European AIDS Treatment Group Eurasian Harm Reduction Network Stop-TB Forum (Germany) Stronger Together, Association for Support of People Living with HIV Skopje (Macedonia) Terra-1530 NGO (Romania, Moldova) Fondazione LILA Milano ONLUS (Italy) The HIV Justice Network (UK) Gay-alliance, PO (Ukraine) The John Mordaunt Trust, London (UK) TB Georgian Coalition (Georgia) Welfare Foundation (Georgia)